Muscle histology vs MRI in Duchenne muscular dystrophy

M. Kinali, V. Arechavala-Gomeza, S. Cirak, A. Glover, M. Guglieri, L. Feng, K. G. Hollingsworth, D. Hunt, H. Jungbluth, H. P. Roper, R. M. Quinlivan, J. A. Gosalakkal, S. Jayawant, A. Nadeau, L. Hughes-Carre, A. Y. Manzur, Eugenio Maria Mercuri, J. E. Morgan, V. Straub, K. BushbyC. Sewry, M. Rutherford, F. Muntoni

Risultato della ricerca: Contributo in rivistaArticolo in rivista

102 Citazioni (Scopus)


There are currently no effective treatments to halt the muscle breakdown in Duchenne muscular dystrophy (DMD), although genetic-based clinical trials are being piloted. Most of these trials have as an endpoint the restoration of dystrophin in muscle fibers, hence requiring sufficiently well-preserved muscle of recruited patients. The choice of the muscles to be studied and the role of noninvasive methods to assess muscle preservation therefore require further evaluation.
Lingua originaleEnglish
pagine (da-a)346-353
Numero di pagine8
Stato di pubblicazionePubblicato - 2011


  • Adolescent
  • Child
  • Foot
  • Humans
  • Leg
  • Magnetic Resonance Imaging
  • Male
  • Muscle, Skeletal
  • Muscular Dystrophy, Duchenne


Entra nei temi di ricerca di 'Muscle histology vs MRI in Duchenne muscular dystrophy'. Insieme formano una fingerprint unica.

Cita questo